Navigation Links
BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX (GM-CSF) in the Journal of Clinical Oncology
Date:11/2/2009

e and death," said Dr. Howard Kaufman of the Rush University Medical Center in Chicago, principal investigator of an ongoing Phase 3 OPTiM(TM) study with OncoVEX (GM-CSF) in Stage III and Stage IV melanoma. "The ability to simply administer the vaccine in the office setting represents a significant improvement in quality of life for patients with melanoma."

"We believe that OncoVEX (GM-CSF) is the most advanced clinical development program globally using viruses for cancer therapy, and we are committed to the further evaluation of OncoVEX (GM-CSF) for the treatment of metastatic melanoma and other solid tumors," said Robert Coffin, PhD, Founder & Chief Technology Officer of BioVex.

About the Phase 2 OncoVEX (GM-CSF) Study in Melanoma

The Phase 2 trial enrolled 50 patients with Stage IIIc (10 patients) and Stage IV melanoma (40 patients) who were treated with OncoVEX (GM-CSF) as a stand-alone therapy. The trial was designed to measure overall objective response, which is defined as a complete response, where disease is completely eliminated, or partial response, where there is a more than 30% reduction in disease burden. The vast majority of patients who entered the study had progressive disease after having failed conventional and experimental prior therapies. Fourteen objective systemic responses (28% objective response rate) were ultimately achieved, including on an extension protocol to which four patients were transferred having completed the main study, including 10 complete responses. Responses have been maintained for up to nearly four years so far. Responses were observed in patients with all stages of disease, including the complete resolution of un-injected visceral deposits.

About the OPTiM(TM) Phase 3 Study

BioVex has now begun a multi-national, randomized Phase 3 OPTiM Study to assess the efficacy and safety of treatment with OncoVEX (GM-CSF) as compared to subcut
'/>"/>

SOURCE BioVex Inc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
2. BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
3. BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
4. BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
5. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
6. PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
7. Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call
8. ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement
9. Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc.
10. Stryker Announces Change in Chairman of the Board of Directors
11. Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 Reportlinker.com announces that ... in its catalogue:   ... for Medical Devices in the US Market ... Changing Regulatory and Reimbursement Scenario ...   Summary ...
(Date:5/21/2013)... REDWOOD CITY, Calif. , May 21, ... ACRX ), a specialty pharmaceutical company ... innovative therapies for the treatment of acute ... demonstrating that in a placebo-controlled Phase 3 ... PCA (patient-controlled analgesia) System (NanoTab System), the ...
(Date:5/21/2013)... and HENDERSONVILLE, N.C. , May ... procurement program for home medical equipment is forcing ... Carolina to lay off employees or close ... of service and products received by Medicare beneficiaries, says ... defective and dangerous program, the Centers for Medicare ...
Breaking Medicine Technology:Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 2North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 3North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 4
... Pharmaceuticals, a leading provider of contract manufacturing services ... multi-year contract-manufacturing agreement with an undisclosed biotechnology company. ... of a sterile liquid product used in processing ... of JHP noted, “We look forward to serving ...
... Cosmetic dentist in Torrance , Dr. Robert Mondavi, DDS, ... provide a safe and comfortable visit for area patients. ... revolutionizing dental examinations. The digital x-ray systems are used ... dental problems at or below the gum line. Early ...
Cached Medicine Technology:JHP Pharmaceuticals Announces Multi-Year Contract Manufacturing Agreement 2Torrance Dentist, Dr. Robert Mondavi, Now Uses Digital X-Rays for Comfort and Safety of the Patients 2
(Date:5/21/2013)... May 21, 2013 Diversity Focus, a ... environments for all residents in the Creative Corridor region, ... Survey at a news conference on Thursday, May 23rd ... study, conducted in 2008. , The survey ... lead and support efforts that attract, nurture and retain ...
(Date:5/21/2013)... Healing Center announces their participation in the CannaCommunity Solutions ... including MedMar Healing Center, doctors, and clubs, are coming together ... raise food to help area kids who have been impacted ... , “We like being able to give back to ... of MedMar Healing Center. “Taking part in the food drive ...
(Date:5/21/2013)... 2013) A paper recently published in the ... physicians and scientists at the University of Colorado School ... for pulmonary fibrosis can be used to identify individuals ... looked at a fairly common variant of the gene ... the mucous produced by the bronchial tubes. While this ...
(Date:5/21/2013)... 2013) Research into genetic features of pulmonary fibrosis ... School of Medicine may lead to improved treatment of ... online by JAMA . , The study found ... some cases of pulmonary fibrosis, a chronic progressive disease ... result of the study, researchers may want to consider ...
(Date:5/21/2013)... agency for scientific and technological research So Paulo Research ... announced an investment estimated in US$ 680 million to ... a period of up to eleven years, subject to ... , Funding for the 17 RIDCs will come from ... support personnel, and infrastructure). Host institutions will participate in ...
Breaking Medicine News(10 mins):Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Research at the cutting edge of knowledge 2
... stress disorder (PTSD) can occur in civilians, too and ... new review article in the Journal of the American ... a type of anxiety disorder that occurs after a person ... 20 to 51 percent of patients with an orthopaedic injury. ...
... present, it can take up to a year before a ... are diffuse and are often mistaken for other diseases. However, ... whether someone has the disease or not", says Christer Wingren, ... The test can also determine how far the disease has ...
... Seven out of ten hospital nurses who took part in ... administer intramuscular injections - despite the potential risks of sciatic ... hip site recommended by the nursing literature. ... the Journal of Advanced Nursing , found that younger, ...
... News) -- People at risk for celiac disease ought to ... symptoms, a new study suggests. Celiac disease is a ... the person consumes gluten, a protein found in wheat, rye ... has grown rapidly in recent decades, but, according to the ...
... May 9 (HealthDay News) -- Some adults with attention-deficit/hyperactivity ... everyday situations, a combination that appears to run in ... Hospital study that included 83 participants -- 23 with ... (DESR), 33 with neither condition -- plus their siblings. ...
... children taken to hospital emergency departments (EDs) for a head ... parents, concerns. Yet true traumatic brain injury is uncommon. A ... head trauma, led by Children,s Hospital Boston and UC Davis, ... use of head CT by as much as half without ...
Cached Medicine News:Health News:Post-traumatic stress disorder common following significant orthopedic trauma 2Health News:Post-traumatic stress disorder common following significant orthopedic trauma 3Health News:New test could give SLE patients a more tolerable life 2Health News:Most nurses don't use recommended intramuscular injection site despite potential risks 2Health News:Most nurses don't use recommended intramuscular injection site despite potential risks 3Health News:More People May Benefit From Going Gluten-Free 2Health News:ADHD With Poor Emotional Control Seems to Run in Families 2Health News:Large study finds CT scans are frequently unnecessary after head injury in children 2Health News:Large study finds CT scans are frequently unnecessary after head injury in children 3
... a high throughput primary or backup ... offers performance and reliability equal to ... instruments. The advanced technology of the ... strips delivers reproducible and accurate results, ...
... for the World Health Organization as a ... been widely used in clinical trials and ... methods. Urine samples are diluted in buffer ... (enzyme labelled immunoassay with magnetic second antibody ...
... Estrone Enzyme Immunosorbent Assay (EIA) Kit ... of Estrone in serum. The procedure ... immunoassay where there is competition between ... antigen for a fixed number of ...
... Helmer presents the ... with innovative solutions for ... more sophisticated features than ... Bank Refrigerators are at ...
Medicine Products: